Empowering investors with access to the best research, experts and opportunities.
Star-crossed stock brokers in China have been told to stop using ‘feng shui’ to predict market trends after the market regulator issued a stern warning against the practice.
Australian biotechnology company Prescient Therapeutics is enrolling up to 12 new patients for the next round of trials on its target therapy PTX-100 for blood cancers.
Australia faces “four more decades of debt” under the current Budget settings, Shadow Treasurer Jim Chalmers said in a scathing National Press Club address on Tuesday.
Last night saw Treasurer Josh Frydenberg deliver his fourth federal budget and already reams have been written about its contents, especially with an election looming and living costs starting to put pressure on Australians’ hip pockets.
Commodity prices have rapidly rallied as supply chain weakness and war in Europe converge with surging demand for materials used in green energy technology, pushing the market towards a new supercycle.
Australian-owned gold explorer Far East Gold has listed on the ASX after a successful IPO campaign that raised $11.73 million from investors.
Full-service smart city technology company Traffic Technologies has inked a $1.3 million deal to supply energy-saving street lights in NSW, with almost 100,000 in need of upgrade.
Investors are pouring money into influencer marketing and content creation platforms as consumers worldwide spend hundreds of billions on purchases facilitated by social media.
Last night’s Federal Budget included a raft of measures to support Australia’s small businesses and sole traders in an effort to stimulate investment and job creation.
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In November, Samuel Berridge, from Perennial Partners, selected Jindalee Resources as one of his three favourite stocks, noting the business owns one…
There’s now less than a week until the Federal Budget is released, and already the rumour mills are turning at full-speed as commentators speculate about what we might see.
Wellnex Life is eyeing further growth and partnership opportunities after signing a “lucrative” supply agreement with global pharmaceutical giant GlaxoSmithKline (GSK).
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.